Sergei O. Podvyaznikov

Sergei O. Podvyaznikov

Auto-generated profile, based on publicly available information

Sergei O. Podvyaznikov

Russian Medical Academy of Continuous Professional Education

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2017 in Endocrine Surgery
Verified
Journal Article
Open access
PDF file
DBDmitry G. Beltsevich
Dmitry G. Beltsevich
VVVladimir E. Vanushko
Vladimir E. Vanushko
PRPavel O. Rumiantsev
Pavel O. Rumiantsev
GMGalina A. Melnichenko
Galina A. Melnichenko
NKNikolay S. Kuznetsov
Nikolay S. Kuznetsov
ВЛВоробьев Сергей Леонидович
Воробьев Сергей Леонидович
В представленных клинических рекомендациях обсуждаются современные подходы к диагностике и лечению дифференцированного рака щитовидной железы у взрослых. Изменения в настоящей редакции Клинических рекомендаций касаются показаний к пункционной биопсии, скринингового определения концентрации кальцитонина, унификации заключений цитологического исследования, новых подходах к послеоперационной динамической стратификации риска рецидива, показаний к супрессивной и заместительной терапии, таргетной терапии йоднегативных форм дифференцированного рака щитовидной железы.

31 December 2020 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
DBDmitry Beltsevich
Dmitry Beltsevich
AMAli M. Mudunov
Ali M. Mudunov
VVVladimir E. Vanushko
Vladimir E. Vanushko
PRPavel O. Rumiantsev
Pavel O. Rumiantsev
GMGalina A. Mel’nIchenko
Galina A. Mel’nIchenko
НАНевольских Алексей Алексеевич
Невольских Алексей Алексеевич
Differentiated thyroid cancer Дифференцированный рак щитовидной железы

7 April 2023 in Endocrine Surgery
Verified
Journal Article
Open access
PDF file
ECEvgeny L. Choynzonov
Evgeny L. Choynzonov
IRI. V. Reshetov
I. V. Reshetov
SIS. A. Ivanov
S. A. Ivanov
APA. P. Polyakov
A. P. Polyakov
MKM. A. Kropotov
M. A. Kropotov
EKE. V. Kostromina
E. V. Kostromina
The article presents a draft of clinical recommendations for the diagnosis and treatment of differentiated thyroid cancer in adult patients, which provides a modern examination algorithm, discusses the basic principles of laboratory, instrumental diagnostics and treatment approaches.

7 April 2023 in Endocrine Surgery
Verified
Journal Article
Open access
PDF file
NSN. V. Severskaya
N. V. Severskaya
ECEvgeny L. Choynzonov
Evgeny L. Choynzonov
IRI. V. Reshetov
I. V. Reshetov
SIS. A. Ivanov
S. A. Ivanov
APA. P. Polyakov
A. P. Polyakov
EKE. V. Kostromina
E. V. Kostromina
The article presents a draft of clinical recommendations for the diagnosis and treatment of medullary thyroid cancer in adult patients, which provides a modern examination algorithm, discusses the basic principles of laboratory, instrumental diagnostics and treatment approaches.

30 December 2023 in Head and Neck Tumors (HNT)
Verified
Journal Article
Open access
PDF file
ИГИ. М. Гельфанд
И. М. Гельфанд
MKM. A. Kropotov
M. A. Kropotov
MIM. T. Isaeva
M. T. Isaeva
SPS. O. Podvyaznikov
S. O. Podvyaznikov
Skin cancer is the second most common tumor among non-melanoma malignant skin neoplasms, accounting for 20 % of cases. In the Russian federation in 2022, this pathology was identified in 79,124 people. The peak incidence occurs in the age range of 60–70 years. Considering the increasing life expectancy, the incidence of skin cancer is expected to rise. Despite the fact that regional metastases occur in 0.3–16 % of cases, the risk of metastasis can increase up to 48 % depending on high-risk factors. Since the presence of regional metastases is a key prognostic factor, special attention should be given to preventive interventions in the areas of regional metastasis.

11 April 2022 in Head and Neck Tumors (HNT)
Verified
Journal Article
Open access
PDF file
AMA. M. Mudunov
A. M. Mudunov
ИГИ. М. Гельфанд
И. М. Гельфанд
MKM. A. Kropotov
M. A. Kropotov
AAA. A. Akhundov
A. A. Akhundov
SPS. O. Podvyaznikov
S. O. Podvyaznikov
AKA. S. Krylov
A. S. Krylov
Introduction. Oral squamous cell carcinoma is associated with a high risk of regional metastasis even in early stages (T1–2N0M0). Morphological examination reveals concealed metastases in 20 % of removed clinically unaffected lymph nodes.Objective – to evaluate the effectiveness of flow cytometry for detection of concealed metastases in sentinel lymph nodes as an indication for cervical lymph node dissection in patients with stage сT1–2N0M0 oral squamous cell carcinoma.Materials and methods. This study included 27 patients, including 13 patients (48.1 %) with stage T1N0M0 cancer and 14 patients with stage T2N0M0 cancer (51.9 %). At the first stage, all participants underwent primary tumor removal and cervical lymph node dissection with sentinel lymph node examination. After mobilization, half of these lymph nodes was used for routine morphological examination followed by immunohistochemical examination, while the second half of them was analyzed using flow cytometry. Then we compared the results obtained.Results. We examined 46 removed sentinel lymph nodes from 27 patients. Conventional histological examination revealed 4 concealed metastases (8.7 %). Polymerase chain reaction allowed us to detect another 16 metastases (37.8 %). Levels I, II, and III lymph nodes were most frequently affected. Flow cytometry demonstrated that 20 % of patients with a 4 mm invasion had concealed metastases, whereas patients with a 4 to 8 mm invasion had concealed metastases in 60 % of cases. Median follow-up time was 20.4 ± 11.7 months (range: 2.2 to 42.5 months; median 19.5 months). All participants were alive during this time. Seventeen out of 27 patients with stage T1–2N0M0 disease (63 %) were found to have concealed metastases, while the remaining ten patients (37 %) had no metastasis. One patient with stage T1N0M0 oral floor squamous cell carcinoma underwent the removal of the primary tumor and sentinel lymph node. Morphological examination and flow cytometry showed no metastatic lesions. After 14.8 months, the patient developed ipsilateral regional CN3 metastasis. The three-year progression-free survival rate was 94.7 ± 5.1 %.Conclusion. Highly sensible and rapid flow cytometry can become the method of choice in the diagnosis of metastases and deciding on cervical lymph node dissection in patients with cN0 disease. The study is still ongoing.